Evidence map›Paper›PMID 39105805›Full record

ReviewZeitschrift fur Gerontologie und Geriatrie2024

[Prevention of ischemic stroke in old age].

Bernhard Iglseder, J Sebastian Mutzenbach

Abstract readReviewEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Review in Zeitschrift fur Gerontologie und Geriatrie, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bernhard IglsederUniversitätsklinik für Geriatrie der PMU, Uniklinikum Salzburg - Campus Christian-Doppler-Klinik, Ignaz-Harrer-Straße 79, 5020, Salzburg, Österreich. b.iglseder@salk.at.
J Sebastian MutzenbachUniversitätsklinik für Neurologie, neurologische Intensivmedizin und Neurorehabilitation, Uniklinikum Salzburg - Campus Christian-Doppler-Klinik, Salzburg, Österreich.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stroke is one of the main causes of permanent disability and death and the risk increases with age. Primary and secondary prevention therefore have a high priority. The treatment of risk factors, such as high blood pressure, diabetes mellitus and hyperlipidemia is just as important as anticoagulation in atrial fibrillation, in addition to optimization of lifestyle and diet. Platelet function inhibitors play a role in the prophylaxis of recurrence, carotid surgery and stenting are used in selected patients. There is little study evidence for old people, individualized treatment planning takes functional status and comorbidities into account.

Indexed as

Ischemic StrokeAgedAged, 80 and overAnticoagulantsEvidence-Based MedicineFemaleHumansMalePlatelet Aggregation InhibitorsRisk FactorsTreatment OutcomeAnticoagulantsPlatelet Aggregation InhibitorsAged, 80 and overCerebrovascular diseasesPrimary preventionRisk factorsSecondary prevention

Identifiers

PMID39105805
PMCPMC11315753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.